Carboplatin Accord Healthcare 10 mg/ml

A phase II study evaluating the efficacy and the safety of TPEx followed by a maintenance with the combination of avelumab and cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN).

Induction chemotherapy followed by standard concurrent chemoradiotherapy in cervical cancer with para-aortic lymph node involvement: A phase III, multicenter, parallel-group randomized, controlled trial - ONCOCOL-01